Tatva Chintan Pharma Chem rises on starting commercial production of new facility at Dahej Manufacturing Plant
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Tatva Chintan Pharma Chem is currently trading at Rs. 1688.00, up by 9.85 points or 0.59% from its previous closing of Rs. 1678.15 on the BSE.
The scrip opened at Rs. 1717.95 and has touched a high and low of Rs. 1728.00 and Rs. 1685.00 respectively. So far 865 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2649.10 on 22-Sep-2022 and a 52 week low of Rs. 1606.00 on 29-Mar-2023.
Last one week high and low of the scrip stood at Rs. 1728.00 and Rs. 1640.00 respectively. The current market cap of the company is Rs. 3743.68 crore.
The promoters holding in the company stood at 79.17%, while Institutions and Non-Institutions held 15.26% and 5.57% respectively.
Tatva Chintan Pharma Chem has successfully commenced its commercial production from New Facility at its Dahej Manufacturing plant situated at Dahej, Bharuch, Gujarat. The company has started its commercial production of new facility on April 5, 2023.
Tatva Chintan Pharma Chem is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals.
